MSD “regrets” tactics used to silence doctor over prescription adviceBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4599 (Published 14 July 2014) Cite this as: BMJ 2014;349:g4599
- Fabio Turone
The drug company Merck Sharp and Dohme has said that it “regrets” the intimidating tactics adopted by its Italian branch to silence a public health doctor who had criticised the prescription of the cholesterol lowering drug ezetimibe.
Alberto Donzelli, the head of education, appropriateness, and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial